Test-Retest Reliability of DiaMem
An Exploratory Study on the Test-Retest Reliability of the Memory Function Assessment Tool DiaMem
1 other identifier
observational
30
0 countries
N/A
Brief Summary
The goal of this observational study is to learn how reliable the DiaMem memory assessment tool is when used repeatedly over a short period. The main question it aims to answer is:
- How consistent are the DiaMem test scores when the same person takes the test multiple times? Researchers will also compare DiaMem with another digital memory test called MemTrax to gather initial information. Participants will:
- Be adults aged 60 or older.
- Complete a standard memory test and a thinking skills test.
- Be randomly split into two groups (A and B).
- Take memory tests once a day for 6 days in a row. Group A will take the DiaMem test 3 times first, then the MemTrax test 3 times. Group B will take the tests in the opposite order.
- Answer a short questionnaire about how easy the tests were to use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2026
CompletedStudy Start
First participant enrolled
February 14, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
February 17, 2026
February 1, 2026
4 months
February 10, 2026
February 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Test-retest reliability of the DiaMem total score
The test-retest reliability (repeatability) of the total score from the DiaMem digital memory assessment tool will be evaluated. Reliability will be quantified using the Intraclass Correlation Coefficient (ICC), calculated from the DiaMem total scores obtained across three test sessions.
Days 1 to 3 in Group A and Days 4 to 6 in Group B
Secondary Outcomes (4)
Test-retest reliability of the MemTrax accuracy score
For Group A, sessions occur on Days 4 to 6; for Group B, on Days 1 to 3.
Actual completion time for the DiaMem and MemTrax assessments
6 days (Recorded at each of the 6 assessment sessions)
Mean DiaMem and MemTrax scores by age group and education level
At completion of all 6 assessment sessions (Day 6)
System Usability Scale (SUS) score for the DiaMem and MemTrax tools
Assessed once per tool: after the first DiaMem session (Day 1 for Group A / Day 4 for Group B) and after the first MemTrax session (Day 4 for Group A / Day 1 for Group B)
Study Arms (2)
Group A
3 sessions of DiaMem testing followed by 3 sessions of MemTrax testing.
Group B
3 sessions of MemTrax testing followed by 3 sessions of DiaMem testing.
Eligibility Criteria
The study will enroll a community-based sample of 30 older adults aged 60 years and above. Participants will be stratified by age into three groups (60-69, 70-79, and ≥80 years) to ensure representation across older age ranges. While the primary focus is on validating a measurement tool and not on treating a specific disease, the sample may include individuals with subjective memory complaints or varying cognitive abilities as typically found in a community setting, provided they meet all eligibility criteria.
You may qualify if:
- Age ≥ 60 years, regardless of gender. Willing and able to provide signed informed consent.
You may not qualify if:
- Corrected visual acuity insufficient to see text/images on a mobile phone screen.
- Corrected hearing inability to hear prompts at the phone's maximum volume. Severe upper limb dysfunction (e.g., severe arthritis, Parkinson's tremor) preventing stable phone operation.
- Does not own a smartphone, or owns one that cannot properly run WeChat mini-programs.
- History of severe mental illness (e.g., major depressive disorder, bipolar disorder, schizophrenia).
- History of long-term alcohol or substance abuse.
- Hospitalization, emergency visit, or major life event (e.g., myocardial infarction, marriage/divorce, fall) within the past month.
- Use of antipsychotics, antidepressants, antiepileptics, sedatives, or plans to use them within the next two weeks.
- Planned travel (e.g., inter-city) or other major arrangements likely to interrupt study participation within the next two weeks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
February 10, 2026
First Posted
February 17, 2026
Study Start
February 14, 2026
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
Individual participant data (IPD) that will be shared include all study-collected, de-identified individual-level data necessary to reproduce the primary and secondary outcomes reported in future publications. This specifically encompasses: Participant Baseline Characteristics: Age group, sex, and education level. Assessment Scores: For the DiaMem tool: Total score, immediate memory score, and delayed memory score for each of the three sessions. For the MemTrax tool: Accuracy rate and average response time for each of the three sessions. Usability Data: System Usability Scale (SUS) score for each tool. Administrative Data: Actual completion time for each assessment session, and the assigned study group (A or B). Data will be rigorously de-identified. All direct personal identifiers (e.g., name, contact information, initials, specific birth dates) will be removed. Participants will only be referenced by a unique, anonymized study ID.